The Rapid Androgen Disruption Activity Reporter (RADAR) Test Guideline describes an aquatic assay that utilizes transgenic Oryzias latipes (O. latipes, Japanese medaka) eleutheroembryos at day post hatch zero, in a multi-well format to detect chemicals active on the androgen axis. The RADAR assay was designed as a screening tool to provide a short-term assay to measure the response of eleutheroembryos to chemicals potentially active on the androgen axis. Test organisms are exposed for 72 hours in six-well plates in the presence and absence of a co-treatment with 17-methyl testosterone. The assay comprises five concentrations of the test chemical. At the end of the exposure, fluorescence imaging is measured and transformed into a numerical format; the statistical analysis and data interpretation procdure enable to determine whether the test chemical is considered active or not active.
Test No. 251: Rapid Androgen Disruption Activity Reporter (RADAR) assay
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
25 June 202511 Pages
-
25 June 202522 Pages
-
25 June 202524 Pages
Related publications
-
2 July 2026115 Pages
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
Report
Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins
2 July 202663 Pages -
Report
Assays addressing the Adverse Outcome Pathway Key Event on Keratinocyte activation
2 July 202698 Pages